antiphospholipid antibodies and antiphospholipid syndrome during pregnancy: diagnostic concepts
Clicks: 273
ID: 196572
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
273 views
53 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #358 of 644 articles by views in sudebno-meditsinskaia ekspertiza
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 644 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Antiphospholipid syndrome comprises of a wide spectrum of clinical and obstetric manifestations linked to the presence of antiphospholipid antibodies. APS was described in the context of lupus and later as an isolated syndrome or primary APS. The Classification Criteria was designed for the definition of APS in epidemiologic and clinical studies is generally misused for clinical diagnostic decisions on an individual basis. The presence of aPL, especially the lupus anticoagulant test, is known to be a recurrence predictor for arterial events and fetal death. When the serologic assays are used it is important that the validated tests for anticardiolipin and anti-beta 2 glycoprotein I and cut-off are employed. Pathogenic mechanisms are various, beyond the inhibition of anticoagulant action of beta 2 glycoprotein I and other natural anticoagulants, including cell-mediated events involving endothelial and dendritic cells, monocytes and platelets. The mechanisms are not self-exclusive and may in fact be related, offering different targets for potential future therapies. During pregnancy a high-risk care setting, following a protocol of tests and prediction of events, is imperative. The relationship of aPL and infertility is not clear, w
| Reference Key |
levy2015frontiersantiphospholipid
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Roger A Levy;Flavia eCunha;Guilherme R de Jesús;Nilson R de Jesús |
| Journal | sudebno-meditsinskaia ekspertiza |
| Year | 2015 |
| DOI |
10.3389/fimmu.2015.00205
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.